Cargando…

The WorldWide Antimalarial Resistance Network Clinical Trials Publication Library: A Live, Open-Access Database of Plasmodium Treatment Efficacy Trials

Parasite resistance to antimalarial drugs poses a serious threat to malaria control. The WorldWide Antimalarial Resistance Network (WWARN) aims to provide a collaborative platform to support the global malaria research effort. Here, we describe the “WWARN clinical trials publication library,” an ope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takata, Junko, Sondo, Paul, Humphreys, Georgina S., Burrow, Rebekah, Maguire, Brittany, Hossain, Mohammad S., Das, Debashish, Commons, Robert J., Price, Ric N., Guerin, Philippe J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356478/ https://www.ncbi.nlm.nih.gov/pubmed/32431267 http://dx.doi.org/10.4269/ajtmh.19-0706

Ejemplares similares

Diagnostic accuracy of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: protocol for an update to a systematic review and meta-analysis
por: Burrow, Rebekah, et al.
Publicado: (2018)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
por: Commons, Robert J, et al.
Publicado: (2019)

The Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trials
por: Commons, R.J., et al.
Publicado: (2017)

A systematic review of published antimalarial clinical trials: parasite clearance of artemisinin-containing regimens in the treatment of uncomplicated malaria
por: Das, Debashish, et al.
Publicado: (2012)

Evaluating antimalarial efficacy in single-armed and comparative drug trials using competing risk survival analysis: a simulation study
por: Dahal, Prabin, et al.
Publicado: (2019)

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
por: Commons, Robert J, et al.
Publicado: (2018)

The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network
por: Hossain, Mohammad S., et al.
Publicado: (2020)

Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
por: Mehdipour, Parinaz, et al.
Publicado: (2023)

Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis
Publicado: (2019)

The effect of dose on the antimalarial efficacy of artesunate-mefloquine against Plasmodium falciparum malaria: a protocol for systematic review and individual patient data (IPD) meta-analysis
por: Mansoor, Rashid, et al.
Publicado: (2019)

Plasmodium vivax in the Era of the Shrinking P. falciparum Map
por: Price, Ric N., et al.
Publicado: (2020)

Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weighting
por: Dahal, Prabin, et al.
Publicado: (2019)

Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2014)

Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis
por: Commons, Robert J., et al.
Publicado: (2020)

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
por: Commons, Robert J., et al.
Publicado: (2019)

Plasmodium vivax Recurrence Following Falciparum and Mixed Species Malaria: Risk Factors and Effect of Antimalarial Kinetics
por: Douglas, Nicholas M., et al.
Publicado: (2011)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
por: Phyo, Aung Pyae, et al.
Publicado: (2016)

The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
por: Cheah, Phaik Yeong, et al.
Publicado: (2018)

Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs
por: Gruenberg, Maria, et al.
Publicado: (2019)

Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium falciparum Malaria
por: Borrmann, Steffen, et al.
Publicado: (2008)

Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database
por: Tabernero, Patricia, et al.
Publicado: (2014)

Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents
por: van Schalkwyk, Donelly A, et al.
Publicado: (2017)

Bibliometric Analysis of Worldwide Publications on Antimalarial Drug Resistance (2006–2015)
por: Sweileh, Waleed M., et al.
Publicado: (2017)

CMS Centres Worldwide, PS Library
por: Taylor, L
Publicado: (2008)

Early parasitological response following artemisinin-containing regimens: a critical review of the literature
por: Das, Debashish, et al.
Publicado: (2013)

Pyrazoleamide compounds are potent antimalarials that target Na(+) homeostasis in intraerythrocytic Plasmodium falciparum
por: Vaidya, Akhil B., et al.
Publicado: (2014)

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial
por: Thriemer, Kamala, et al.
Publicado: (2023)

A living systematic review protocol for COVID-19 clinical trial registrations
por: Maguire, Brittany J., et al.
Publicado: (2020)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
por: Commons, Robert J, et al.
Publicado: (2020)

Rosetting Responses of Plasmodium-infected Erythrocytes to Antimalarials
por: Lee, Wenn-Chyau, et al.
Publicado: (2022)

Improving the Radical Cure of Plasmodium vivax Malaria
por: Price, Ric N.
Publicado: (2014)

Targeting the Plasmodium falciparum’s Thymidylate Monophosphate Kinase for the Identification of Novel Antimalarial Natural Compounds
por: Enninful, Kweku S., et al.
Publicado: (2022)

High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia
por: Kho, Steven, et al.
Publicado: (2019)

Antimalarials increase vesicle pH in Plasmodium falciparum
Publicado: (1985)

Plasmodium malaria and antimalarial antibodies in the first year of life
por: DOBBS, KATHERINE R., et al.
Publicado: (2016)

Validation of Plasmodium falciparum deoxyhypusine synthase as an antimalarial target
por: Aroonsri, Aiyada, et al.
Publicado: (2019)

The molecular basis of antimalarial drug resistance in Plasmodium vivax
por: Buyon, Lucas E., et al.
Publicado: (2021)

Extrachromosomal DNA amplicons in antimalarial‐resistant Plasmodium falciparum
por: McDaniels, Jennifer M., et al.
Publicado: (2020)

Plasmodium falciparum Nicotinamidase as A Novel Antimalarial Target
por: Donu, Dickson, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9l4ls9epej4vbtsc8hqivi7kc6